{ "template": "Corridor pair risk profile", "pageType": "Corridor pair risk profile", "source": "api", "generatedAt": "2026-08-29T11:48:09.993Z", "seo": { "title": "Ireland exports to Belgium: Trade Route Risk | Yugalinks", "description": "Understand reported exports from Ireland to Belgium, the product routes that need a closer look, and the conditions that may affect planning." }, "publisher": { "name": "Yugalinks", "url": "https://www.yugalinks.com", "email": "support@yugalinks.com", "linkedin": "https://in.linkedin.com/company/yugalinks" }, "exporter": { "iso3": "IRL", "country_name": "Ireland" }, "importer": { "iso3": "BEL", "country_name": "Belgium" }, "latestYear": 2024, "risk": { "exporter_iso3": "IRL", "importer_iso3": "BEL", "all_history_lane_count": 645, "current_lane_count": 505, "current_product_count": 505, "first_observed_last_year": 1999, "latest_data_year": 2024, "current_trade_usd": 13766250166.681583, "attention_trade_usd": 10354288510.562492, "critical_trade_usd": 881014887.0964187, "high_volatility_trade_usd": 9383619552.001951, "unrecovered_drawdown_trade_usd": 3271459626.2386055, "declining_demand_trade_usd": 2250412.687724743, "concentrated_market_trade_usd": 10255156787.945768, "access_friction_trade_usd": 0, "buyer_macro_weakness_trade_usd": 0, "critical_lane_count": 5, "high_attention_lane_count": 58, "high_volatility_lane_count": 302, "unrecovered_drawdown_lane_count": 258, "declining_demand_lane_count": 6, "concentrated_market_lane_count": 167, "access_friction_lane_count": 0, "trade_weighted_volatility_cv": 1.4905430615012163, "trade_weighted_below_peak_pct": 38.949722150531144, "product_concentration_hhi": 1858.3551774765654, "top1_product_share_pct": 33.14735285725861, "top3_product_share_pct": 67.19350603194609, "top_product_hs6": "300220", "top_product_trade_usd": 4563147517.962896, "top_product_description": "Vaccines: for human medicine", "top_attention_product_hs6": "300220", "top_attention_product_reason": "Trade has varied substantially across reported years", "distance_km": 775.6281127929688, "shares_land_border": 0, "shares_official_language": 0, "common_spoken_language_score": null, "has_reported_fta": 1, "avg_applied_tariff_pct": 0, "avg_mfn_tariff_pct": 0, "avg_preferential_tariff_pct": 0, "tariff_advantage_pp": 0, "buyer_biz_entry_days": 5, "buyer_biz_entry_cost_pct": null, "buyer_gdp_mn_latest": 599879.025378, "buyer_gdp_pc_latest": 51768, "buyer_population_latest": 11587.882, "buyer_gdp_5y_cagr_pct": 4.5783569491818055, "buyer_gdp_pc_5y_cagr_pct": 3.918136849252618, "buyer_population_5y_cagr_pct": 0.6353271141561478, "buyer_investment_5y_avg_pct": 23.874000000000002, "buyer_savings_5y_avg_pct": 24.938, "buyer_macro_resilience_label": "Buyer macro trend resilient", "attention_trade_share_pct": 75.21502504453208, "critical_trade_share_pct": 6.399817498803971, "risk_driver_labels": [ "high_volatility", "unrecovered_drawdown", "declining_buyer_demand", "concentrated_buyer_markets" ], "attention_level": "High attention", "primary_risk_reason": "Buyer-market concentration is the largest observed corridor exposure", "buyer_gdp_mn_2024": 599879.025378, "buyer_gdp_pc_2024": 51768, "buyer_population_2024": 11587.882 }, "history": [ { "year": 1999, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 3531073452.627458, "yoy_growth_pct": null, "cagr_3y_pct": null }, { "year": 2000, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 3709273408.5878534, "yoy_growth_pct": 5.046622743794726, "cagr_3y_pct": null }, { "year": 2001, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 4090743567.466778, "yoy_growth_pct": 10.284228657713124, "cagr_3y_pct": null }, { "year": 2002, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 11297524950.805155, "yoy_growth_pct": 176.172895330157, "cagr_3y_pct": 47.35295598321607 }, { "year": 2003, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 10667603418.613983, "yoy_growth_pct": -5.575748094685807, "cagr_3y_pct": 42.20864725201632 }, { "year": 2004, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 12769869066.711067, "yoy_growth_pct": 19.70700977155586, "cagr_3y_pct": 46.14862352791944 }, { "year": 2005, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 14056847826.286541, "yoy_growth_pct": 10.078245539184216, "cagr_3y_pct": 7.556058347872985 }, { "year": 2006, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 13643145726.86407, "yoy_growth_pct": -2.9430645087360263, "cagr_3y_pct": 8.546515209534288 }, { "year": 2007, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 14207491618.61005, "yoy_growth_pct": 4.136479247852298, "cagr_3y_pct": 3.620015932211884 }, { "year": 2008, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 14941179275.501162, "yoy_growth_pct": 5.164090020859646, "cagr_3y_pct": 2.0545356815496074 }, { "year": 2009, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 18388047895.336952, "yoy_growth_pct": 23.069588794022255, "cagr_3y_pct": 10.460507978349787 }, { "year": 2010, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 11146681437.808693, "yoy_growth_pct": -39.38083313000619, "cagr_3y_pct": -7.769182018667998 }, { "year": 2011, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 12403260946.130589, "yoy_growth_pct": 11.273126583304638, "cagr_3y_pct": -6.016776937844359 }, { "year": 2012, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 11101682134.655188, "yoy_growth_pct": -10.493843652313473, "cagr_3y_pct": -15.481641430829507 }, { "year": 2013, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 9725109112.442139, "yoy_growth_pct": -12.39967966580413, "cagr_3y_pct": -4.445832960082219 }, { "year": 2014, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 9321990592.043703, "yoy_growth_pct": -4.145131080150999, "cagr_3y_pct": -9.080383918712132 }, { "year": 2015, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 9002856321.268356, "yoy_growth_pct": -3.4234562631690224, "cagr_3y_pct": -6.746778532706266 }, { "year": 2016, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 12807780479.31214, "yoy_growth_pct": 42.2635219564154, "cagr_3y_pct": 9.61242793432724 }, { "year": 2017, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 12925570840.827942, "yoy_growth_pct": 0.9196781730141712, "cagr_3y_pct": 11.50996786122802 }, { "year": 2018, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 18168888440.40341, "yoy_growth_pct": 40.56546255592384, "cagr_3y_pct": 26.37155990541602 }, { "year": 2019, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 14208475221.761671, "yoy_growth_pct": -21.797773879411885, "cagr_3y_pct": 3.52006427450704 }, { "year": 2020, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 16392412184.863571, "yoy_growth_pct": 15.370663839825593, "cagr_3y_pct": 8.242474302053227 }, { "year": 2021, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 19227678457.27346, "yoy_growth_pct": 17.296211444877628, "cagr_3y_pct": 1.9059395689895453 }, { "year": 2022, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 16798798567.171156, "yoy_growth_pct": -12.632205679430353, "cagr_3y_pct": 5.74104127510402 }, { "year": 2023, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 18851720551.29765, "yoy_growth_pct": 12.220647660710625, "cagr_3y_pct": 4.769782547270673 }, { "year": 2024, "exporter_iso3": "IRL", "importer_iso3": "BEL", "export_value_usd": 13828740021.497025, "yoy_growth_pct": -26.644679545999693, "cagr_3y_pct": -10.404694691521 } ], "riskLanes": [ { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "300220", "hs_description": "Vaccines: for human medicine", "buyer_imports_latest_usd": 6914085483.027903, "current_below_peak_pct": 46.635837874206494, "lane_volatility_cv": 1.2841504361851555, "attention_level": "High attention", "primary_risk_reason": "Trade has varied substantially across reported years", "risk_driver_labels": [ "high_volatility", "concentrated_buyer_market", "dominant_supplier" ] }, { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "300339", "hs_description": "Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale", "buyer_imports_latest_usd": 3422383529.1697373, "current_below_peak_pct": 0, "lane_volatility_cv": 2.5280129439194248, "attention_level": "High attention", "primary_risk_reason": "Trade has varied substantially across reported years", "risk_driver_labels": [ "high_volatility", "concentrated_buyer_market", "dominant_supplier" ] }, { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "300490", "hs_description": "Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale", "buyer_imports_latest_usd": 18559408073.35605, "current_below_peak_pct": 83.98885396185946, "lane_volatility_cv": 0.8340316596022359, "attention_level": "Watch", "primary_risk_reason": "Current trade remains more than 50% below its historical peak", "risk_driver_labels": [ "unrecovered_drawdown" ] }, { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "300214", "hs_description": "Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale", "buyer_imports_latest_usd": 2327325720.912246, "current_below_peak_pct": 48.464033580292806, "lane_volatility_cv": 0.6604645342258045, "attention_level": "Stable", "primary_risk_reason": "No material risk condition is currently identified", "risk_driver_labels": [] }, { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "293359", "hs_description": "Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof", "buyer_imports_latest_usd": 912630896.839802, "current_below_peak_pct": 78.87773628575344, "lane_volatility_cv": 0.5451972494801611, "attention_level": "High attention", "primary_risk_reason": "Current trade remains more than 50% below its historical peak", "risk_driver_labels": [ "unrecovered_drawdown", "concentrated_buyer_market" ] }, { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "854239", "hs_description": "Electronic integrated circuits: n.e.c. in heading no. 8542", "buyer_imports_latest_usd": 2262822728.0539274, "current_below_peak_pct": 0, "lane_volatility_cv": 3.1153598246052914, "attention_level": "High attention", "primary_risk_reason": "Trade has varied substantially across reported years", "risk_driver_labels": [ "high_volatility", "concentrated_buyer_market", "dominant_supplier" ] }, { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "293399", "hs_description": "Heterocyclic compounds: n.e.c. in headings no. 2933", "buyer_imports_latest_usd": 464484226.8879362, "current_below_peak_pct": 89.3830886387845, "lane_volatility_cv": 0.9461418730451862, "attention_level": "Critical attention", "primary_risk_reason": "Current trade remains more than 50% below its historical peak", "risk_driver_labels": [ "unrecovered_drawdown", "concentrated_buyer_market", "dominant_supplier" ] }, { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "300215", "hs_description": "Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale", "buyer_imports_latest_usd": 5161855767.617946, "current_below_peak_pct": 93.72469974023866, "lane_volatility_cv": 0.9944385234260177, "attention_level": "Critical attention", "primary_risk_reason": "Current trade remains more than 50% below its historical peak", "risk_driver_labels": [ "unrecovered_drawdown", "concentrated_buyer_market", "dominant_supplier" ] }, { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "293379", "hs_description": "Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)", "buyer_imports_latest_usd": 1274155723.6598575, "current_below_peak_pct": 96.3786070902343, "lane_volatility_cv": 1.7755645641138327, "attention_level": "High attention", "primary_risk_reason": "Current trade remains more than 50% below its historical peak", "risk_driver_labels": [ "high_volatility", "unrecovered_drawdown" ] }, { "exporter_iso3": "IRL", "importer_iso3": "BEL", "hs_code": "293590", "hs_description": "Sulphonamides: n.e.c. in heading no. 2935", "buyer_imports_latest_usd": 297815235.506026, "current_below_peak_pct": 88.93331912847671, "lane_volatility_cv": 0.8612085386925559, "attention_level": "Critical attention", "primary_risk_reason": "Current trade remains more than 50% below its historical peak", "risk_driver_labels": [ "unrecovered_drawdown", "concentrated_buyer_market", "dominant_supplier" ] } ], "accessProfile": { "year": 2024, "exporter_iso3": "IRL", "importer_iso3": "BEL", "distance_km": 776, "shares_land_border": 0, "shares_official_language": 0, "shares_ethnic_language": 0, "shared_religion": 0, "shared_legal_system": 0, "shared_colonial_history": 0, "has_fta": 1, "rta_coverage_ratio": 2, "exporter_is_wto": 1, "importer_is_wto": 1, "exporter_is_eu": 1, "importer_is_eu": 1, "importer_gdp_million_usd": 599879.0253780001, "importer_gdp_per_capita_usd": 51767.78857240694, "importer_population": 11587.882, "importer_biz_entry_days": 5, "importer_biz_entry_cost_pct": 5.3, "exporter_gdp_million_usd": 498559.576715, "exporter_gdp_per_capita_usd": 99152.10257187916, "avg_applied_tariff_pct": 0, "avg_mfn_tariff_pct": 0, "avg_preferential_tariff_pct": 0, "tariff_advantage_pp": 0 }, "sourceAttribution": { "publisher": "OECD", "dataset": "Balanced international merchandise trade statistics (BIMTS) - HS2017-6D", "year": 2025, "citation": "OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-29)", "sourceUrl": "https://data-explorer.oecd.org/", "dataflowUrl": "https://sdmx.oecd.org/sti-public/rest/dataflow/OECD.SDD.TPS/DSD_BIMTS_6D@DF_BIMTS_HS2017_6D/1.0", "termsUrl": "https://www.oecd.org/termsandconditions/", "terms": "OECD Terms & Conditions", "accessed": "2026-08-29", "supportingSources": [ { "publisher": "CEPII", "dataset": "BACI bilateral trade flows", "release": "202601", "citation": "Gaulier, G. and Zignago, S. (2010), BACI: International Trade Database at the Product-Level. The 1994-2007 Version, CEPII Working Paper No. 2010-23.", "sourceUrl": "https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html", "datasetUrl": "https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37", "licenseUrl": "https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf", "license": "Etalab 2.0 Open Licence", "accessed": "2026-08-29" } ] }, "links": { "canonical": "https://www.yugalinks.com/trade/corridor/IRL-BEL/risk", "html": "https://www.yugalinks.com/trade/corridor/IRL-BEL/risk/index.html", "markdown": "https://www.yugalinks.com/trade/corridor/IRL-BEL/risk/index.md", "json": "https://www.yugalinks.com/trade/corridor/IRL-BEL/risk/index.json", "jsonLd": "https://www.yugalinks.com/trade/corridor/IRL-BEL/risk/index.ld.json", "home": "https://www.yugalinks.com/", "tradeHub": "https://www.yugalinks.com/trade/", "dataSources": "https://www.yugalinks.com/data-sources", "methodology": "https://www.yugalinks.com/methodology", "workspace": "https://www.yugalinks.com/app/corridors", "contact": "https://www.yugalinks.com/contact", "email": "mailto:support@yugalinks.com", "linkedin": "https://in.linkedin.com/company/yugalinks" } }